Compare GRFS & TMHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | TMHC |
|---|---|---|
| Founded | 1940 | 1936 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.0B |
| IPO Year | N/A | 2012 |
| Metric | GRFS | TMHC |
|---|---|---|
| Price | $7.84 | $59.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $10.15 | ★ $78.75 |
| AVG Volume (30 Days) | 682.6K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.77 |
| Revenue | N/A | ★ $4,762,059,000.00 |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $6.50 | $9.07 |
| P/E Ratio | $18.67 | ★ $7.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.19 | $51.90 |
| 52 Week High | $11.14 | $72.27 |
| Indicator | GRFS | TMHC |
|---|---|---|
| Relative Strength Index (RSI) | 27.72 | 30.58 |
| Support Level | $7.64 | $57.56 |
| Resistance Level | $9.11 | $60.69 |
| Average True Range (ATR) | 0.29 | 1.64 |
| MACD | -0.12 | -0.80 |
| Stochastic Oscillator | 2.99 | 10.34 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.